COVID-19 vaccine round-up: Johnson & Johnson begins Phase 3 trials in the United States

A large scale trial has kicked off today. Johnson & Johnson's coronavirus vaccine began its Phase 3 clinical trials. This is the fourth COVID-19 vaccine candidate to enter the final stage here in the US.